breast cancer
Conditions
Interventions
Group 1 :Sentinel lymph node surgery with contrast enhanced ultrasonography and blue dye methods
Sponsors
Sichuan Cancer Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Women aged 18-70 years; 2. According to the 7th edition of the American Joint Committee on Cancer (AJCC) staging system, primary invasive breast cancer with clinical stage of at least T0-4, N1-2, M0 before initial treatment; 3. ECOG score is 0 or 1; 4. Have completed or plan to receive neoadjuvant chemotherapy (the regimen is at the discretion of the patients medical team, and have received at least 6 cycles of neoadjuvant therapy containing anthracyclines and/or taxanes, and patients with HER-2 positive breast cancer should receive a full course of anti-HER-2 therapy); 5. Axillary lymph node biopsy before chemotherapy confirmed positive lymph nodes; 6. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Breast cancer or inflammatory breast cancer during pregnancy; 2. History of previous axillary surgery (including patients with previous history of sentinel lymph node surgery or lymph node biopsy to pathologically confirm the status of the axillary); 3. According to the 7th edition of the American Joint Committee on Cancer (AJCC) staging system, patients with clinical stage of M1 or cN3 before initial treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The false negative rate (FNR) for SLN surgery; | — |
Countries
China
Contacts
Public ContactExian Mou
Sichuan Cancer Hospital
Outcome results
None listed